A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary. The RUNX1 (AML1, CBFA2) gene is a member of the runt transcription factor family, responsible for DNA binding and heterodimerization of other non‐DNA binding transcription factors. RUNX1 plays an important part in regulating haematopoiesis and it is frequently disrupted by illegitimate somatic recombination in both acute myeloid and lymphoblastic leukaemia. Germline mutations of RUNX1 have also recently been described and are dominantly associated with inherited leukaemic conditions. We have identified a unique point mutation of the RUNX1 gene (A107P) in members of a family with autosomal dominant inheritance of thrombocytopenia. One member has developed acute myeloid leukaemia (AML).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100 · cited 7×
“Mutations were clustered across the Runt domain in six FPD/AML pedigrees and were predicted to influence conformation of the final gene product in affected individuals (Song et al, 1999).”
BackgroundMethodInfluentialDimerization with PEBP2β protects RUNX1/AML1 from ubiquitin–proteasome‐mediated degradation
Huang, G., Shigesada, K., Ito, K., Wee, H., Yokomizo, T., & Ito, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.723 · Cited by 283
Cited by
Role of RUNX1 in hematological malignancies
Sood, R., Kamikubo, Y., & Liu, P. (2017) · Blood · doi:10.1182/blood-2016-10-687830 · Cited by 494
Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia
Osato, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207779 · Cited by 268
Owen, C. J., Toze, C. L., Koochin, A., Forrest, D. L., Smith, C. A., Stevens, J. M., Jackson, S. C., Poon, M.-C., Sinclair, G. D., Leber, B., et al. (2008) · Blood · doi:10.1182/blood-2008-05-156745 · Cited by 242
Self-citationHeller, P. G., Glembotsky, A. C., Gandhi, M. J., Cummings, C. L., Pirola, C. J., Marta, R. F., Kornblihtt, L. I., Drachman, J. G., & Molinas, F. C. (2005) · Blood · doi:10.1182/blood-2005-01-0050 · Cited by 104
“Several additional chromosomal abnormalities have been reported in FPD/AML patients who develop leukemia, including -7, +8, +21, 20q-, 5q- and 11q-.(1,2,4,5) FISH analysis with a chromosome 5 probe in our patient with CMMoL revealed an abnormal pattern although the underlying abnormality could not be further character…”
BackgroundNakao, M., Horiike, S., Fukushima‐Nakase, Y., Nishimura, M., Fujita, Y., Taniwaki, M., & Okuda, T. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04966.x · Cited by 34
“Similarly, affected family members of FPD/AML pedigree with a haplo-insufficient AML1 allele generally have 20–40 years of latency prior to development of overt leukaemia (Song et al, 1999; Buijs et al, 2001; Michaud et al, 2002; Walker et al, 2002).”
Background
Metadata
- Authors
- Walker, L. C., Stevens, J., Campbell, H., Corbett, R., Spearing, R., Heaton, D., Macdonald, D. H., Morris, C. M., & Ganly, P.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2002-06
- Volume
- 117
- Issue
- 4
- Pages
- 878-881
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2115055038
- Cited by
- 61
- References
- 2
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia. https://app.cochat.ai/papers/10.1046/j.1365-2141.2002.03512.x
- The paper
- Walker, L. C., Stevens, J., Campbell, H., Corbett, R., Spearing, R., Heaton, D., Macdonald, D. H., Morris, C. M., & Ganly, P. (2002). A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.2002.03512.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.